Riyadh – Mubasher: The net profits of Dallah Healthcare Company hit SAR 357.29 million in the first nine months (9M) of 2024, up 44.96% year-on-year (YoY) from SAR 246.47 million.
The medical group posted revenues valued at SAR 2.39 billion as of 30 September 2024, higher by 12.17% than SAR 2.13 billion in 9M-23, according to the interim financial statements.
Earnings per share (EPS) amounted to SAR 3.66 in 9M-24, compared to SAR 2.53 in 9M-23.
Financials for Q3-24
In the third quarter (Q3) of 2024, Dallah Healthcare recorded a 27.59% leap in net profit to SAR 126.15 million, versus SAR 98.87 million a year earlier.
Revenues witnessed a 13.05% YoY rise to SAR 847.73 million in July- September 2024, versus SAR 749.82 million.
Quarterly, the Q3-24 net profits hiked by 12.79% from the SAR 111.84 million generated in Q2-24, while the revenues increased by 10.74% from SAR 765.18 million.
Dividends
The board members approved, on 7 November 2024, cash dividends worth SAR 48.69 million, equivalent to 5% of the share nominal value, for Q3-24.
Dallah Healthcare will disburse a dividend of SAR 0.50 per share for 97.38 million eligible shares.
Eligibility and payment dates for the dividends will be 17 November and 1 December 2024, respectively.
